Q&A: Novo Nordisk research chief discusses streamlined R&D, asset integration and role of AI

In its second-quarter results, Novo disclosed a partial miss in a Phase 3 diabetes trial of CagriSema. And it ended work on an…

endpoints.news20 g fa

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

cnbc.com4 mesi fa

Novo Nordisk’s rise to become an obesity powerhouse, only to find itself in a brutal battle for market share with its U.S. | Novo…

fiercebiotech.com18 g fa

Novo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug…

economictimes.indiatimes.com20 g fa

CNBC's Charlotte Reed will travel to Copenhagen to speak with Novo Nordisk's new CEO after a bumpy few months.

cnbc.com9 mesi fa

In the air-conditioned haven of the Hilton just downriver from the American Diabetes Association’s 2026 Scientific Sessions in…

fiercepharma.com2 mesi fa

Other newsrooms on this story